InterCure Ltd.

INCR

$5.26

-2.95%

N/A-$0.16

Salud

Fabricantes de medicamentos: especialidad y genéricos

NASDAQ

Negociación activa

InterCure Ltd., incluidas sus subsidiarias, participa activamente en todo el ciclo de vida de los productos de cannabis medicinal. Esto abarca todo, ...

Métricas clave de INCR

Instantánea

Último / TTM · 6 periodos

Capitalización

$192.14M

ROCE

-5.7%

EV / EBITDA

-5.94x

-7.1% YoY

Rendimiento FCF

6.9%

-1.2% YoY

Ciclo de conversión de efectivo

272.2d

Ratio corriente

1.48

Resumen rápido

TTM —

Positive CCC

Métricas clave

Último / TTM · 6 periodos

Tendencia de valoración

Tendencia de valoración table

Metric	2021	2022	2023	2024	2025	TTM
Market CapTotal market value of all shares outstanding.	$771.57M	$524.90M	$212.61M	$275.80M	$163.91M	$192.14M
Enterprise ValueCompany value including debt and cash adjustments.	$684.27M	$547.47M	$307.15M	$408.89M	$300.46M	$328.68M
EV / SalesHow many dollars investors pay per dollar of sales.	3.11x	1.41x	0.86x	1.71x	1.11x	1.22x
EV / EBITDAValuation multiple versus operating earnings before non-cash charges.	21.95x	7.80x	-12.85x	-7.97x	-41.20x	-5.94x
Net Debt / EBITDALeverage ratio using net debt divided by EBITDA.	-2.80	0.32	-3.96	-2.59	-18.72	-2.47

Retornos + indicador ROCE

ROCE más reciente

-5.7%

Prev year 1.4%

Retornos + indicador ROCE table

Metric	2021	2022	2023	2024	2025	TTM
ROEProfit generated from shareholders' equity.	1.0%	8.9%	-13.6%	-17.1%	-9.0%	-8.6%
ROAProfit generated from total assets.	0.7%	4.7%	-7.9%	-8.9%	-5.2%	-5.2%
ROICReturn generated on invested operating capital.	1.9%	9.7%	-7.5%	-11.2%	-4.8%	-13.2%
ROCEOperating return on long-term capital used.	5.7%	7.8%	-7.4%	-12.5%	1.4%	-5.7%
Earnings YieldEarnings as a percentage of market value.	0.6%	8.5%	-29.1%	-24.6%	-21.8%	-21.7%

Calidad del flujo de caja

Calidad del flujo de caja table

Metric	2021	2022	2023	2024	2025	TTM
FCFFCash flow available to all capital providers.	$12.96M	$46.18M	$-31.14M	$-54.09M	$29.69M	$13.29M
FCFECash flow available to equity holders after debt flows.	$76.82M	$169.25M	$-118.23M	$-63.56M	$-15.84M	$13.29M
FCF YieldFree cash flow divided by market capitalization.	1.4%	6.0%	-26.5%	-25.9%	8.1%	6.9%
Income QualityHow well accounting earnings are backed by cash flow.	3.43	1.17	0.84	0.92	-0.46	-0.47
Capex / OCFShare of operating cash flow spent on capital expenditures.	56.1%	38.5%	-4.9%	-6.5%	21.1%	21.1%

Eficiencia operativa

Eficiencia operativa table

Metric	2021	2022	2023	2024	2025	TTM
DSOAverage days to collect cash from customers.	62.4d	46.5d	62.7d	275.8d	208.7d	208.7d
DIOAverage days inventory stays before being sold.	192.7d	228.9d	154.9d	219.3d	166.4d	171.9d
DPOAverage days the company takes to pay suppliers.	183.1d	197.0d	114.3d	135.7d	104.9d	108.4d
Operating CycleTime from buying inventory to collecting receivables.	255.1d	275.4d	217.6d	495.1d	375.1d	380.5d
Cash Conversion CycleNet days cash is tied in operations.	72.0d	78.4d	103.3d	359.4d	270.1d	272.2d

Instantánea

Último / TTM: —

Capitalización

$192.14M

ROE

-8.6%

Rendimiento FCF

6.9%

Ratio corriente

1.48

Upstream

Organigram Global Inc.NASDAQ:OGI Charlotte's Web Holdings Inc.OTC:CWBHF Tilray Brands Inc.NASDAQ:TLRYCookies (SF Brands LLC)Praetorian Global Inc. (Binske)Cannasoul R&D Ltd.General cultivation input suppliers (lighting, HVAC, hydroponics, nutrients, growing media)

Downstream

S.L.E. Ltd. (subsidiary of Teva Pharmaceutical Industries)NYSE:TEVAMedical Cannabis Patients – IsraelMedical Cannabis Patients – Germany / EUCookies Brand Pharmacies (Germany, UK, Austria)Botanico Ltd. (ISHI – acquired entity)

Empresas proxy

Organigram Global Inc.NASDAQ:OGITikun Olam-Cannbit Pharmaceuticals Ltd.TASE:TKUNSeach Medical Group Ltd.TASE:SEMGTeva Pharmaceutical Industries Ltd.NYSE:TEVA Tilray Brands Inc.NASDAQ:TLRY

Sobre nosotrosPolítica de privacidadTérminos de servicioAviso legalDirectorio de accionesETFÍndicesCarteras 13FPrecios objetivoHerramientas gratuitasMapa tecnológicoÚnete a nuestro Slack

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal

No se encontraron acciones que coincidan

InterCure Ltd.

Métricas clave de INCR

Métricas clave

Tendencia de valoración

Retornos + indicador ROCE

Calidad del flujo de caja

Eficiencia operativa

Instantánea

Cadena de suministro de INCR

Upstream

Downstream

Empresas proxy

Métricas clave de INCR

Métricas clave

Tendencia de valoración

Retornos + indicador ROCE

Calidad del flujo de caja

Eficiencia operativa

Instantánea

Cadena de suministro de INCR

Upstream

Downstream

Empresas proxy